1 Day
Source:
Lebanese Forces
Lebanese Forces
Ready to play
Ready to play
Researchers from the Karolinska Institute and Stockholm University in Sweden have developed a new pill-based medication to treat type 2 diabetes and obesity. It works through a different mechanism than GLP-1 drugs like semaglutide. As a result, the medication does not affect the brain or appetite centers and offers a non-injective alternative to this treatment.
Notice: This Is an AI-Generated Summary
Comments (0)